Barrett 食管

Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014;63:7-42.

• 全文
• 摘要

Bonino JA, Sharma P. Barrett's esophagus. Curr Opin Gastroenterol. 2006;22:406-411.

• 摘要

Guardino JM, Khandwala F, Lopez R, et al. Barrett's esophagus at a tertiary care center: association of age on incidence and prevalence of dysplasia and adenocarcinoma. Am J Gastroenterol. 2006;101:2187-2193.

• 摘要

Oh DS, Hagen JA, Fein M, et al. The impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg. 2006;10:787-797.

• 摘要

Fitzgerald RC. Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2006;55:1810-1818.

• 摘要

Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. 2017;49:191-198.

• 全文
• 摘要

Shaheen NJ, Falk GW, Iyer PG, et al. ACG Clinical Guideline: diagnosis and management of Barrett's esophagus. Am J Gastroenterol. 2016;111:30-50;quiz 51.

• 全文
• 摘要

Fernando HC, Murthy SC, Hofstetter W, et al; Society of Thoracic Surgeons. The Society of Thoracic Surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia. Ann Thorac Surg. 2009;87:1993-2002.

• 全文
• 摘要

Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology. 2004;127:310-330.

• 全文
• 摘要

Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: The Prague C & M criteria. Gastroenterology. 2006;131:1392-1399.

• 摘要

National Institute for Health and Care Excellence. Barrett's oesophagus: ablative therapy. August 2010. http://guidance.nice.org.uk (last accessed 18 July 2017).

• 全文

Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009;360:2277-2288.

• 全文
• 摘要

Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett's esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1245-1255.

• 全文
• 摘要

Rees JR, Lao-Sirieix P, Wong A, et al. Treatment for Barrett's oesophagus. Cochrane Database Syst Rev. 2010;(1):CD004060.

• 全文
• 摘要

Sharma P, Falk GW, Weston AP, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2006;4:566-572.

• 摘要

Cooper BT, Chapman W, Neumann CS, et al. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitor up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther. 2006;23:727-733.

• 摘要

1.  Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014;63:7-42.

• 全文
• 摘要

2.  Bonino JA, Sharma P. Barrett's esophagus. Curr Opin Gastroenterol. 2006;22:406-411.

• 摘要

3.  Shaheen NJ. Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 2005;128:1554-1566.

• 摘要

4.  Flejou JF, Svrcek M. Barrett's oesophagus: a pathologist's view. Histopathology. 2007;50:3-14.

• 摘要

5.  Peters JH. The importance of symptom assessment in the surgical treatment of gastroesophageal reflux disease and Barrett's esophagus. Surg Endosc. 2006;20(suppl 2):S456-S461.

• 摘要

6.  Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825-1831.

• 摘要

7.  Spechler SJ. Clinical practice. Barrett's esophagus. N Engl J Med. 2002;346:836-842.

• 摘要

8.  Westhoff B, Brotze S, Weston A, et al. The frequency of Barrett's esophagus in high-risk patients with chronic GERD. Gastrointest Endosc. 2005;61:226-231.

• 摘要

9.  Dickman R, Kim JL, Camargo L, et al. Correlation of gastroesophageal reflux disease symptom characteristics with long-segment Barrett's esophagus. Dis Esophagus. 2006;19:360-365.

• 摘要

10.  Cameron AJ. Epidemiology of Barrett's esophagus and adenocarcinoma. Dis Esophagus. 2002;15:106-108.

• 摘要

11.  Guardino JM, Khandwala F, Lopez R, et al. Barrett's esophagus at a tertiary care center: association of age on incidence and prevalence of dysplasia and adenocarcinoma. Am J Gastroenterol. 2006;101:2187-2193.

• 摘要

12.  Prasad GA, Bansal A, Sharma P, et al. Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am J Gastroenterol. 2010;105:1490-1502.

• 摘要

13.  Post PN, Siersema PD, Van Dekken H. Rising incidence of clinically evident Barrett's oesophagus in The Netherlands: a nation-wide registry of pathology reports. Scand J Gastroenterol. 2007;42:17-22.

• 摘要

14.  Coleman HG, Bhat S, Murray LJ, et al. Increasing incidence of Barrett's oesophagus: a population-based study. Eur J Epidemiol. 2011;26:739-745.

• 摘要

15.  Fein M, Maroske J, Fuchs KH. Importance of duodenogastric reflux in gastro-oesophageal reflux disease. Br J Surg. 2006;93:1475-1482.

• 摘要

16.  Oh DS, Hagen JA, Fein M, et al. The impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg. 2006;10:787-797.

• 摘要

17.  Shalauta MD, Saad R. Barrett's esophagus. Am Fam Physician. 2004;69:2113-2118.

• 摘要

18.  Odze RD. Update on the diagnosis and treatment of Barrett esophagus and related neoplastic precursor lesions. Arch Pathol Lab Med. 2008;132:1577-1585.

• 摘要

19.  Peters CJ, Fitzgerald RC. Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma. Aliment Pharmacol Ther. 2007;25:1253-1269.

• 全文
• 摘要

20.  Chak A, Chen Y, Vengoechea J, et al. Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2012;21:376-383.

• 全文
• 摘要

21.  Wang DH, Souza RF. Biology of Barrett's esophagus and esophageal adenocarcinoma. Gastrointest Endosc Clin N Am. 2011;21:25-38.

• 全文
• 摘要

22.  Fitzgerald RC. Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2006;55:1810-1818.

• 摘要

23.  Vallbohmer D, DeMeester SR, Oh DS, et al. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus. Am J Gastroenterol. 2006;101:1458-1466.

• 摘要

24.  Colleypriest BJ, Farrant JM, Slack JM, et al. The role of Cdx2 in Barrett's metaplasia. Biochem Soc Trans. 2010;38:364-369.

• 摘要

25.  Sikkema M, de Jonge PJ, Steyerberg EW, et al. Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8:235-244.

• 摘要

26.  Winberg H, Lindblad M, Lagergren J, et al. Risk factors and chemoprevention in Barrett’s esophagus - an update. Scand J Gastroenterol. 2012;47:397-406.

• 摘要

27.  Taylor JB, Rubenstein JH. Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus. Am J Gastroenterol. 2010;105:1729-1737.

• 全文
• 摘要

28.  Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol. 2005;162:1050-1061.

• 摘要

29.  Chak A, Ochs-Balcom H, Falk G, et al. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev. 2006;15:1668-1673.

• 全文
• 摘要

30.  Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143:199-211.

• 摘要

31.  Veugelers PJ, Porter GA, Guernsey DL, et al. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett's esophagus and esophageal adenocarcinoma. Dis Esophagus. 2006;19:321-328.

• 摘要

32.  De Jonge PJ, Steyerberg EW, Kuipers EJ, et al. Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus. Am J Gastroenterol. 2006;101:1421-1429.

• 摘要

33.  Omer ZB, Ananthakrishnan AN, Nattinger KJ, et al. Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis. Clin Gastroenterol Hepatol. 2012;10:722-727.

• 全文
• 摘要

34.  Weusten B, Bisschops R, Coron E, et al. Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. 2017;49:191-198.

• 全文
• 摘要

35.  Shaheen NJ, Falk GW, Iyer PG, et al. ACG Clinical Guideline: diagnosis and management of Barrett's esophagus. Am J Gastroenterol. 2016;111:30-50;quiz 51.

• 全文
• 摘要

36.  Andrici J, Tio M, Cox MR, et al. Hiatal hernia and the risk of Barrett's esophagus. J Gastroenterol Hepatol. 2013;28:415-431.

• 摘要

37.  Shariff MK, Bird-Lieberman EL, O'Donovan M, et al. Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus. Gastrointest Endosc. 2012;75:954-961.

• 摘要

38.  Bhardwaj A, Hollenbeak CS, Pooran N, et al. A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett's esophagus in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2009;104:1533-1539.

• 摘要

39.  Kadri SR, Lao-Sirieix P, O'Donovan M, et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ. 2010;341:c4372.

• 全文
• 摘要

40.  Mannath J, Subramanian V, Hawkey CJ, et al. Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Endoscopy. 2010;42:351-359.

• 摘要

41.  Ngamruengphong S, Sharma VK, Das A. Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis. Gastrointest Endosc. 2009;69:1021-1028.

• 摘要

42.  Qumseya BJ, Wang H, Badie N, et al. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett's esophagus: a meta-analysis and systematic review. Clin Gastroenterol Hepatol. 2013;11:1562-1570.

• 全文
• 摘要

43.  Wu J, Pan YM, Wang TT, et al. Confocal laser endomicroscopy for detection of neoplasia in Barrett's esophagus: a meta-analysis. Dis Esophagus. 2014;27:248-254.

• 摘要

44.  Waxman I, Konda VJ. Endoscopic techniques for recognizing neoplasia in Barrett's esophagus: which should the clinician use? Curr Opin Gastroenterol. 2010;26:352-360.

• 摘要

45.  Fernando HC, Murthy SC, Hofstetter W, et al; Society of Thoracic Surgeons. The Society of Thoracic Surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia. Ann Thorac Surg. 2009;87:1993-2002.

• 全文
• 摘要

46.  Nurgalieva Z, Lowrey A, El-Serag HB. The use of cytokeratin stain to distinguish Barrett's esophagus from contiguous tissues: a systematic review. Dig Dis Sci. 2007;52:1345-1354.

• 摘要

47.  Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology. 2004;127:310-330.

• 全文
• 摘要

48.  Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: The Prague C & M criteria. Gastroenterology. 2006;131:1392-1399.

• 摘要

49.  Bhat SK, McManus DT, Coleman HG, et al. Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study. Gut. 2015;64:20-25.

• 摘要

50.  Sharma P, Hawes RH, Bansal A, et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial. Gut. 2013;62:15-21.

• 摘要

51.  Oelschlager BK, Barreca M, Chang L, et al. Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery. Ann Surg. 2003;238:458-464.

• 摘要

52.  National Institute for Health and Care Excellence. Barrett's oesophagus: ablative therapy. August 2010. http://guidance.nice.org.uk (last accessed 18 July 2017).

• 全文

53.  Mino-Kenudson M, Hull MJ, Brown I, et al. EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointest Endosc. 2007;66:660-666; quiz 767, 769.

• 摘要

54.  Phoa KN, van Vilsteren FG, Weusten BL, et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014;311:1209-1217.

• 全文
• 摘要

55.  Tseng EE, Wu TT, Yeo CJ, et al. Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome - an update. J Gastrointest Surg. 2003;7:164-171.

• 摘要

56.  Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology. 2000;118:670-677.

• 摘要

57.  Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009;360:2277-2288.

• 全文
• 摘要

58.  Rice TW, Sontag SJ. Debate: esophagectomy is the treatment of choice for high grade dysplasia in Barrett's esophagus. Am J Gastroenterol. 2006;101:2177-2184.

• 摘要

59.  Gilbert S, Jobe BA. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma. Surg Oncol Clin N Am. 2009;18:523-531.

• 摘要

60.  Attwood SE, Lundell L, Hatlebakk JG, et al. Medical or surgical management of GERD patients with Barrett's esophagus: the LOTUS trial 3-year experience. J Gastrointest Surg. 2008;12:1646-1654.

• 摘要

61.  Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett's esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1245-1255.

• 全文
• 摘要

62.  Velanovich V. Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: initial results and lessons learned. Surg Endosc. 2009;23:2175-2180.

• 摘要

63.  Wani S, Puli SR, Shaheen NJ, et al. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol. 2009;104:502-513.

• 摘要

64.  Rees JR, Lao-Sirieix P, Wong A, et al. Treatment for Barrett's oesophagus. Cochrane Database Syst Rev. 2010;(1):CD004060.

• 全文
• 摘要

65.  Li YM, Li L, Yu CH, et al. A systematic review and meta-analysis of the treatment for Barrett's esophagus. Dig Dis Sci. 2008;53:2837-2846.

• 摘要

66.  Wang KK, Song LM, Buttar N, et al. Barrett's esophagus after photodynamic therapy: Risk of cancer development during long-term follow-up. Gastroenterology. 2004;126(suppl 2):A-50.

67.  Gossner L, May A, Stolte M, et al. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc. 1999;49:8-12.

• 摘要

68.  Dulai GS, Jensen DM, Cortina G, et al. Randomized trial of argon plasma coagulation versus multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc. 2005;61:232-240.

• 摘要

69.  Kastelein F, Spaander MC, Biermann K, et al. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus. Gastroenterology. 2011;141:2000-2008;quiz e13-e14.

• 全文
• 摘要

70.  Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103:1049-1057.

• 全文
• 摘要

71.  Sharma P, Falk GW, Weston AP, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2006;4:566-572.

• 摘要

72.  Cooper BT, Chapman W, Neumann CS, et al. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitor up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther. 2006;23:727-733.

• 摘要

73.  Vieth M, Schubert B, Lang-Schwarz K, et al. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study. Endoscopy. 2006;38:1201-1205.

• 摘要

74.  Gurski RR, Peters JH, Hagen JA, et al. Barrett's esophagus can and does regress after antireflux surgery: A study of prevalence and predictive features. J Am Coll Surg. 2003;196:706-712.

• 摘要

75.  Bowers SP, Mattar SG, Smith CD, et al. Clinical and histologic follow-up after antireflux surgery for Barrett's esophagus. J Gastrointest Surg. 2002;6:532-538.

• 摘要

76.  Ye W, Chow WH, Lagergren J, et al. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology. 2001;121:1286-1293.

• 摘要

77.  Lagergren J, Ye W, Lagergren P, et al. The risk of esophageal adenocarcinoma after antireflux surgery. Gastroenterology. 2010;138:1297-1301.

• 摘要

78.  Crockett SD, Lippmann QK, Dellon ES, et al. Health-related quality of life in patients with Barrett's esophagus: a systematic review. Clin Gastroenterol Hepatol. 2009;7:613-623.

• 摘要

79.  Beales IL, Vardi I, Dearman L. Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma. Eur J Gastroenterol Hepatol. 2012;24:917-923.

• 摘要

80.  Chang EY, Morris CD, Seltman AK, et al. The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett esophagus: a systematic review. Ann Surg. 2007;246:11-21.

• 全文
• 摘要